Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,584.14
(
1.19%
)
US TECH 100
23,516.00
(
1.00%
)
Dow Jones
46,212.70
(
1.39%
)
Brent Oil
97.88
(
-9.48%
)
Bitcoin
70,564.63
(
4.02%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 199020

Thursday, 10/27/2016 12:43:38 PM

Thursday, October 27, 2016 12:43:38 PM

Post# of 257269
Re: ADXS 2016 news flow

Based on today’s AZN news (#msg-126101997), the fifth bullet item in #msg-119786171 may be delayed beyond the end of 2016:

Complete enrollment in the combination Phase 1/2 study with [AZN’s] durvalumab for the treatment of HPV-associated head and neck and cervical cancer in late 2016.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today